Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 182   

Articles published

PFE 28.30 +0.02 (0.07%)
price chart
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Big Pharma is undergoing a radical face-lift due to the avalanche of top-selling drugs losing patent protection. The consequences of the aptly named "patent cliff" have been widespread and immense in scope.
Pfizer Now #16 Largest Company, Surpassing AT&T
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock. Many beginning ...
Related articles »  
Should Pfizer Inc. Buy Actavis plc?
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer Inc. Is Kicking The Tires At Actavis PLC  Benzinga
Pfizer Said to Have Approached Actavis About Possible Deal  Bloomberg
Related articles »  
Pfizer Inc. (PFE): Why You Should Sell the Stock [AstraZeneca plc (ADR)]
buyers and sellers Lawrence Meyers: Pfizer Inc. (NYSE:PFE) is the country's largest prescription drug maker, has strong free cash flow, lots of cash, the third-highest dividend yield among the 30 Dow stocks, is attractively valued compared to its peer ...
Multiple Contraction Can Hit Pfizer (PFE)  Seeking Alpha (registration)
Related articles »  
The Most Important Number You Need to Know Before Buying Pfizer Inc. Stock
Every company has one number that defines its success more than any other. For Pfizer (NYSE: PFE ) , the world's largest pharmaceutical company, that number is... $10.7 billion. Pfizer has four blockbuster drugs coming off-patent in the United States ...
Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
PCSK9 inhibitors, and their potential sales, have garnered a lot of interest from investors Pfizer's (NYSE: PFE ) Lipitor peaked at well over $10 billion in annual sales.
AntiCancer, Inc. v. Pfizer, Inc. (Fed. Cir. 2014)
It is with this backdrop that the Federal Circuit decided the Anticancer, Inc. v. Pfizer, Inc. case on Monday, October 20, 2014.
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Pfizer Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Related articles »  
American Express Company (AXP), Wells Fargo & Co (WFC), Pfizer Inc. (PFE ...
Generally, big investors with multi-billion dollar portfolios wait until the last possible date to release their 13F filing, which is not the case for Ken Fisher.
Related articles »  
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?
Unfortunately, these figures imply that if Pfizer does not come back for Astra, Astra's shares will fall. If the company's valuation were to fall to a level similar to the rest of the sector, the shares would only be worth 3,523p. With earnings ...
Related articles »